Slater K Bartlett
Visit Investigator ProfileInvestigation Details
Detailed Analysis
The inspector emphasizes the need for robust validation processes, thorough complaint management, effective CAPA execution, stringent batch testing and release procedures, diligent facility maintenance, well-defined change control procedures, and strong data integrity measures. Attention to detail and risk mitigation are central to the inspector''s approach.
Slater K Bartlett is focused on ensuring thorough process validation, complaint management, CAPA execution, batch manufacturing testing, facility maintenance, change control procedures, and data integrity management. This inspector prioritizes consistency, quality, and risk mitigation in drug manufacturing facilities.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies